CASE REPORT
A RARE CLINICAL CASE OF AN ADVANCED PENILE CANCER IN A 52 YEAR-OLD MAN
,
 
 
 
More details
Hide details
1
Regional Hospital in Biała Podlaska, Poland
 
 
Submission date: 2017-02-21
 
 
Final revision date: 2017-04-02
 
 
Acceptance date: 2017-04-04
 
 
Publication date: 2018-01-24
 
 
Health Prob Civil. 2017;11(4):247-252
 
KEYWORDS
TOPICS
ABSTRACT
The following case study presents a rare advanced penile cancer in a 52 year-old man. The diagnosis of penile cancer is not especially common. Patient with squamous cell carcinoma, which is the most prevalent type of penile cancer, undergo surgical treatment. The first part of the therapy covers a radical penectomy, and the second one − radical pelvic lymphadenectomy. Despite such a drastic surgical procedure, there was a need of further oncological treatment including an adjuvant chemotherapy. Unfortunately, the patient did not continue his treatment. Such advanced stages of penile cancer are very uncommon because of patients being aware of any changes in the genitourinary area. In the early stages of the disease, an isolated resection of penile change or a partial penectomy is usually a sufficient consideration. In such cases, overall survival rates are high. However, more advanced stages typically require a more radical treatment and a systemic approach including chemotherapy and radiotherapy. Then, the results of treatment and prognosis for the patients are not as good as in case of patients with early diagnosed problems.
REFERENCES (11)
1.
Parkin DM, Whelan SL, Ferlay J, Teppo L and Thomas DB Cancer Incidence in Five Continents, Vol. VIII, 2002, IARC Scientific Publications, No. 155, Lyon, IARC.
 
2.
Backes DM, Kurman RJ, Pimenta JM, Smith JS Systematic review of human papillomavirus prevalence in invasive penile cancer. Cancer Causes Control, 2009; 20(4): 449-457.
 
3.
Dillner J, von Krogh G, Horenblas S, Meijer CJ Etiology of squamous cell carcinoma of the penis. Scand J Urol Nephrol Suppl, 2000;(205):189-93.
 
4.
Velazquez EF, Barreto JE, Rodriguez I, Piris A, Cubilla AL, Limitations in the interpretation of biopsies in patients with penile squamous cell carcinoma. Int J Surg Pathol, 2004 Apr;12(2):139-46.
 
5.
Velazquez EF, Cubilla AL Lichen sclerosus in 68 patients with squamous cell carcinoma of the penis: frequent atypias and correlation with special carcinoma variants suggests a precancerous role. Am J Surg Pathol, 2003 Nov;27(11):1448-53.
 
6.
Teichman JM, Sea J, Thompson IM, Elston DM. Noninfectious penile lesions. Am Fam Physician, 2010 Jan 15;81(2):167-74.
 
7.
Renaud-Vilmer C, Cavelier-Balloy B, Verola O, Morel P, Servant JM, Desgrandchamps F, et al. Analysis of alterations adjacent to invasive squamous cell carcinoma of the penis and their relationship with associated carcinoma. J Am Acad Dermatol, 2010 Feb;62(2):284-90. doi: 10.1016/j.jaad.2009.06.087.
 
8.
Pizzocaro G., Piva L Adjuvant and neoadjuvant vincristine, bleomycin, and methotrexate for inguinal metastases from squamous cell carcinoma of the penis. Acta Oncol, 1988;27(6b):823-4.
 
9.
Leijte JA, Kerst JM, Bais E, Antonini N, Horenblas S Neoadjuvant chemotherapy in advanced penile carcinoma. Eur Urol, 2007 Aug;52(2):488-94. Epub 2007 Feb 14.
 
10.
Bermejo C, Busby JE, Spiess PE, Heller L, Pagliaro LC, Pettaway CA. Neoadjuvant chemotherapy followed by aggressive surgical consolidation for metastatic penile squamous cell carcinoma. J Urol, 2007 Apr;177(4):1335-8.
 
11.
Patel MI, Yuminaga Y, Bang A, Lawrentschuk N, Skyring T and Smith DP (2016), Volume-outcome relationship in penile cancer treatment: a population based patterns of care and outcomes study from Australia. BJU Int, 2016 Oct;118 Suppl 3:35-42. doi: 10.1111/bju.13626.
 
eISSN:2354-0265
ISSN:2353-6942
Journals System - logo
Scroll to top